Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice

• Main Authors: Zakiyatul Faizah, Bella Amanda, Faisal Yusuf Ashari, Efta Triastuti, Rebecca Oxtoby, Anny Setijo Rahaju, M Aminudin Aziz, Maria Inge Lusida, Delvac Oceandy
• Format: Article PeerReviewed
• Language: English; Indonesian; English; Indonesian
• Published: Multidisciplinary Digital Publishing Intitute 2020
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/122260/1/3%20ARTIKEL.pdf; https://repository.unair.ac.id/122260/2/3%20etik.pdf; https://repository.unair.ac.id/122260/4/3%20turnitin.pdf; https://repository.unair.ac.id/122260/8/Karil%20%281%29-3.pdf; https://repository.unair.ac.id/122260/; https://www.mdpi.com/journal/molecules; https://doi.org/10.3390/molecules25194381
• Institution: Universitas Airlangga

Abstract Diabetes mellitus (DM) is one of the major causes of death in the world. There are two types of DM-type 1 DM and type 2 DM. Type 1 DM can only be treated by insulin injection whereas type 2 DM is commonly treated using anti-hyperglycemic agents. Despite its effectiveness in controlling blo...